SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Sell Steven – ‘4’ for 11/18/22 re: agilon health, inc.

On:  Tuesday, 11/22/22, at 4:04pm ET   ·   For:  11/18/22   ·   As:  Director and Officer   ·   Accession #:  1209191-22-58341   ·   File #:  1-40332

Previous ‘4’:  ‘4’ on 4/20/22 for 4/14/22   ·   Next:  ‘4’ on 4/18/23 for 4/14/23   ·   Latest:  ‘4’ on 4/17/24 for 4/14/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/22/22  Sell Steven                       4          Dir.,Off.   1:5K   agilon health, inc.               DONNELLEY FIN… File16/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 Submission -- doc4.xml/3.6                   HTML      6K 




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
Plain Text rendering:  Form 4 Submission
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0306
Document Type:  4
Period of Report:  11/18/22
Not Subject to Section 16:  0
Issuer:
Issuer CIK:  1831097
Issuer Name:  agilon health, inc.
Issuer Trading Symbol:  AGL
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1479123
Owner Name:  Sell Steven
Reporting Owner Address:
Owner Street 1:  C/O AGILON HEALTH, INC.
Owner Street 2:  6210 E HWY 290, SUITE 450
Owner City:  AUSTIN
Owner State:  TX
Owner ZIP Code:  78723
Owner State Description:
Reporting Owner Relationship:
Is Director?  Yes
Is Officer?  Yes
Is Ten Percent Owner?  No
Is Other?  No
Officer Title:  CEO & President
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  11/18/22
Deemed Execution Date:
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  P
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  2,900
Transaction Price Per Share:
Value:  17.1395
Footnote ID:  F1
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  2,900
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  By trust
Footnote ID:  F2
Non-Derivative Holding:
Security Title:
Value:  Common Stock
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  48,765
Footnote ID:  F3
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $17.12 to $17.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Footnote - F2These shares of common stock are held in the Steven J. Sell and Margaret D. Williams Revocable Inter Vivos Trust Agreement.
Footnote - F3Includes restricted stock units.
Remarks:
Owner Signature:
Signature Name:  /s/ Timothy Bensley, as Attorney-in-Fact
Signature Date:  11/22/22


Top
Filing Submission 0001209191-22-058341   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 1:23:45.2am ET